Optho Remedies Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 6.31 M
- Company Age 48 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 2.20 Cr
- Satisfied Charges ₹ 29.12 K
- Revenue Growth -98.62%
- Profit Growth -498.34%
- Ebitda -117.50%
- Net Worth -99.29%
- Total Assets -43.33%
About Optho Remedies
Optho Remedies Private Limited (ORPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 May 1976 and has a history of 48 years and nine months. Its registered office is in Allahabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.31 M.
The company currently has active open charges totaling ₹2.20 Cr. The company has closed loans amounting to ₹29,120.00, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Agarwal and Rajesh Agarwal serve as directors at the Company.
Company Details
-
Location
Allahabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110UP1976PTC004275
-
Company No.
004275
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 May 1976
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Optho Remedies Private Limited offer?
Optho Remedies Private Limited offers a wide range of products and services, including Common Disease Medicines, Ointment, Eye Drops, Anti Infective Drugs & Medicines, Anti Infective Agent, Hydroxypropyl Methylcellulose Ophthalmic Solution, Bromfenac Sodium, Ear Drops, Gentamicin Eye Drop, Moxifloxacin Eye Drop.
Who are the key members and board of directors at Optho Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Agarwal
|
Director | 29-Sep-1986 | Current |
|
Rajesh Agarwal
|
Director | 31-Dec-1986 | Current |
Financial Performance of Optho Remedies.
Optho Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 98.62% decrease. The company also saw a substantial fall in profitability, with a 498.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Optho Remedies?
In 2018, Optho Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Optho Pharma Private LimitedRajesh Agarwal is a mutual person
-
R'keon Life Sciences Private LimitedRakesh Agarwal is a mutual person
-
Obligo Enterprises LlpRakesh Agarwal is a mutual person
Charges (Loans)
₹21.98 M
₹0.03 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 2.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2005 | State Bank Of India | ₹3.70 M | Open |
| 20 Apr 1999 | State Bank Of India | ₹1.50 Cr | Open |
| 13 Oct 1997 | State Bank Of India | ₹0.40 M | Open |
| 13 Sep 1997 | State Bank Of India | ₹0.80 M | Open |
| 13 Sep 1997 | State Bank Of India | ₹0.80 M | Open |
How Many Employees Work at Optho Remedies?
Optho Remedies has a workforce of 146 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Optho Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optho Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
